Labcorp Holdings Inc. declared a quarterly cash dividend of $0.72 per share of common stock. The dividend is payable on ...

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of ...

Shares of Labcorp Holdings Inc. LH slid 2.16% to $277.74 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.28% to 7,482.71 ...

Patients who get blood work through Labcorp can now receive AI-generated plain-language explanations of their results inside ...

Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered ...

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on ...

Shares of Labcorp Holdings Inc. LH rallied 1.39% to $283.88 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.22% to 7,483 ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Colorectal cancer is highly preventable when detected early, yet approximately 4 in 10 eligible adults are not up to date with recommended screenings. While at-home tests offer convenience, the ...

Physician-founded telehealth service provides on-demand lab orders through LabCorp & Quest, helping patients maintain ...

Labcorp’s NASHnext® is now available through Labcorp OnDemand, a digital interface for patients that provides them with an additional access channel to healthcare professionals within the routine care ...